SignalHF Predictive AI
Provider 
Founded 2016
Sells To B2B
Pricing Model SaaS, Subscription
Ownership Privately Held

FDA-cleared algorithm computing 30-day heart failure hospitalization risk from implantable device data across manufacturers.
SignalHF is an FDA-cleared Class II software medical device that computes a 30-day heart failure hospitalization risk score from 90 days of physiological data, demographics, lead measurements, and episodes recorded by compatible pacemakers, ICDs, and CRT devices. Presented as the first manufacturer-agnostic HF prediction score based on CIED data, it supports Medtronic, Boston Scientific, and Biotronik devices, generates alerts above a threshold, and lists contributing factors with suggested clinician actions.
SignalHF is not available for sale in Europe and is intended as adjunctive clinical decision support rather than a standalone therapy director. FORESEE-HF study results on multi-brand CIED prediction were presented by N. Varma at EHRA 2024, per the product page.
| Attribute | SignalHF Predictive AI | HeartInsight | HeartLogic | TriageHF | |
|---|---|---|---|---|---|
| Provider | |||||
| Founded | 2016 | 1963 | 1979 | 1949 | |
| Sells To | B2B | Hospitals | Consumers, Enterprise | Consumers, Enterprise | |
| Pricing Model | SaaS, Subscription | — | Recurring, Software, Transactional | Recurring, Transactional | |
| Ownership | Privately Held | Privately Held | Public | Public |
Provider 
Founded 2016
Sells To B2B
Pricing Model SaaS, Subscription
Ownership Privately Held
Provider 
Founded 1963
Sells To Hospitals
Pricing Model —
Ownership Privately Held
Provider 
Founded 1979
Sells To Consumers, Enterprise
Pricing Model Recurring, Software, Transactional
Ownership Public
Provider 
Founded 1949
Sells To Consumers, Enterprise
Pricing Model Recurring, Transactional
Ownership Public